medigraphic.com

2018, Number S1

<< Back Next >>

Cuba y Salud 2018; 13 (S1)

Clinical-epidemiological characterization of older adults with Chronic Obstructive Pulmonary Disease in a health area of Pinar del Río

Rosales OAO, González RR

Language: Spanish
References: 39
Page: 384-387
PDF size: 541.48 Kb.


ABSTRACT

Objective: to characterize clinically and epidemiologically the patients with COPD belonging to the University Polyclinic “Pedro Borrás Astorga” during the year 2017.
Materials and Methods: a descriptive and cross-sectional study was carried out in the “Pedro Borrás Astorga” University Polyclinic in the city of Pinar del Río, Cuba during the year 2017. The universe of study consisted of 202 patients diagnosed with COPD belonging to that area. of health. In the research, descriptive statistics were used, using percentage as a summary measure for qualitative and quantitative variables, respecting the principles of medical ethics.
Results: the age group of 65 and over (53%) prevailed, as well as the male sex (58.9%). Regarding the habit of smoking in patients with chronic obstructive pulmonary disease (68.3%) presented this habit. Among the associated comorbidities, arterial hypertension (35.1%) and diabetes mellitus (12.4%) stood out, while shortacting bronchodilators and oral steroids were the most used drugs with 55.5% and 43.6%. % respectively.
Conclusions: the research enriches the scientific study dedicated to the clinical-epidemiological behavior of the noncommunicable disease in the community, as well as the planning of strategies dedicated to the control and prevention of chronic obstructive pulmonary disease.


REFERENCES

  1. Johanne ssen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Rev Int j tuberc lung dis [Internet]. 2015 [citado 12 Ene 2018]; 9(8): 926-932. Disponible en: http://www.ingentaconnect.com/content/iuatld/ijtld/2005/00000009/00000008/art00018

  2. Tzanakis N, Anagnostopoulou U, Filaditaki V, Christaki P, Siafakas N. Prevalence of COPD in Greece. Rev Chest [Internet]. 2014 [citado 12 Ene 2018]; 125: 892-900. Disponible en: http://journal.chestnet.org/article/S0012-3692%2815%2931925-5/abstract

  3. González J, Marín M, Sánchez-Salcedo P, Zulueta JJ. Lung cancer screening in patients with chronic obstructive pulmonary disease. Rev Ann Trans Med [Internet]. 2016 [citado 12 Ene 2018]; 4: 160. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860483/

  4. Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study. Rev Thorax [Internet]. 2013 [citado 15 Ene 2018]; 57(1): 29–33. Disponible en: http://thorax.bmj.com/content/57/1/29.short

  5. Solanes I, Casan P, Sangenis M, Calaf N, Giraldo BGR. Factores de riesgo de mortalidad en la EPOC. Rev Arch Bronconeumol [Internet]. 2014 [citado 15 Ene 2018]; 43:445-9. Disponible en: http://www.sciencedirect.com/science/article/pii/S0300289607711055

  6. López Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology [Internet]. 2016 [citado 15 Ene 2018]; 21: 14–23. Disponible en: http://scholar.google. com.cu/scholar?hl=es&as_sdt=0%2C5&q=35.%09Global+strategy+for+the+diagnosis%2C+management+and+prevention+of+COPD%2C+Global+Initiative+for +Chronic+Obstructive+Lung+Disease+%28GOLD%29+2015&btnG

  7. Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Rev Lancet Respir Med [Internet]. 2015 [citado 15 Ene 2018];3: 631-9. Disponible en: http://www.sciencedirect.com/science/article/pii/ S2213260015002416

  8. Pavasini R, D’Ascenzo F, Campo G, Biscaglia S, Ferri A, Contoli M, et al. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and metaanalysis. Rev Int J Cardiol [Internet]. 2015 [citado 19 Ene 2018]; 191:187-93. Disponible en: http://www.sciencedirect.com/science/article/pii/S0167527315010232

  9. Grosdidier S, Ferrer A, Faner R, Piñero J, Roca J, Cosío B, et al. Network medicine analysis of COPD multimorbidities. Rev Respir Res [Internet]. 2014 [citado 19 Ene 2018];15: 111. Disponible en: http://respiratory-research.biomedcentral.com/articles/10.1186/s12931-014-0111-4

  10. Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M4, et al. Global Multimorbidity Patterns: A Cross-Sectional, Population-Based, Multi-Country Study. J Gerontol A Biol SciMedSci [Internet]. 2016 [citado 19 Ene 2018]; 71:205-14. Disponible en: http://academic.oup.com/biomedgerontology/article/71/2/205/2605626

  11. Kohansal R, Martinez CP, Agusti A, Buist AS. The Natural History of Chronic Airflow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort. Rev Am J Respir Crit Care Med [Internet]. 2015 [citado 21 Ene 2018]; 180(1): 3-10. Disponible en: http://www.atsjournals.org/doi/abs/10.1164/rccm.200901-0047OC

  12. Esteban C, Quintana JM, Aburto M, Moraza J, Capelastegui A. A simple score for assessing stable chronic obstructive pulmonary disease. QJM [Internet]. 2016 [citado 21 Ene 2018]; 99:751-928. Disponible en: http://academic.oup.com/qjmed/article/99/11/751/2261128

  13. Johanne ssen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Rev Int j tuberc lung

  14. dis [Internet]. 2015 [citado 12 Ene 2018]; 9(8): 926-932. Disponible en: http://www.ingentaconnect.com/content/iuatld/ijtld/2005/00000009/00000008/art00018

  15. Tzanakis N, Anagnostopoulou U, Filaditaki V, Christaki P, Siafakas N. Prevalence of COPD in Greece. Rev Chest [Internet]. 2014 [citado 12 Ene 2018]; 125: 892-900.

  16. Disponible en: http://journal.chestnet.org/article/S0012-3692%2815%2931925-5/abstract

  17. González J, Marín M, Sánchez-Salcedo P, Zulueta JJ. Lung cancer screening in patients with chronic obstructive pulmonary disease. Rev Ann Trans Med [Internet].

  18. 2016 [citado 12 Ene 2018]; 4: 160. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860483/

  19. Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long

  20. term follow up study. Rev Thorax [Internet]. 2013 [citado 15 Ene 2018]; 57(1): 29–33. Disponible en: http://thorax.bmj.com/content/57/1/29.short

  21. Solanes I, Casan P, Sangenis M, Calaf N, Giraldo BGR. Factores de riesgo de mortalidad en la EPOC. Rev Arch Bronconeumol [Internet]. 2014 [citado 15 Ene 2018];

  22. 43:445-9. Disponible en: http://www.sciencedirect.com/science/article/pii/S0300289607711055

  23. López Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology [Internet]. 2016 [citado 15 Ene 2018]; 21: 14–23. Disponible en: http://scholar.google.

  24. com.cu/scholar?hl=es&as_sdt=0%2C5&q=35.%09Global+strategy+for+the+diagnosis%2C+management+and+prevention+of+COPD%2C+Global+Initiative+for

  25. +Chronic+Obstructive+Lung+Disease+%28GOLD%29+2015&btnG

  26. Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review

  27. and meta-analysis. Rev Lancet Respir Med [Internet]. 2015 [citado 15 Ene 2018];3: 631-9. Disponible en: http://www.sciencedirect.com/science/article/pii/

  28. S2213260015002416

  29. Pavasini R, D’Ascenzo F, Campo G, Biscaglia S, Ferri A, Contoli M, et al. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation

  30. of chronic obstructive pulmonary disease: Systematic review and metaanalysis. Rev Int J Cardiol [Internet]. 2015 [citado 19 Ene 2018]; 191:187-93. Disponible en:

  31. http://www.sciencedirect.com/science/article/pii/S0167527315010232

  32. Grosdidier S, Ferrer A, Faner R, Piñero J, Roca J, Cosío B, et al. Network medicine analysis of COPD multimorbidities. Rev Respir Res [Internet]. 2014 [citado 19 Ene

  33. 2018];15: 111. Disponible en: http://respiratory-research.biomedcentral.com/articles/10.1186/s12931-014-0111-4

  34. Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M4, et al. Global Multimorbidity Patterns: A Cross-Sectional, Population-Based, Multi-Country Study.

  35. J Gerontol A Biol SciMedSci [Internet]. 2016 [citado 19 Ene 2018]; 71:205-14. Disponible en: http://academic.oup.com/biomedgerontology/article/71/2/205/2605626

  36. Kohansal R, Martinez CP, Agusti A, Buist AS. The Natural History of Chronic Airflow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort. Rev

  37. Am J Respir Crit Care Med [Internet]. 2015 [citado 21 Ene 2018]; 180(1): 3-10. Disponible en: http://www.atsjournals.org/doi/abs/10.1164/rccm.200901-0047OC

  38. Esteban C, Quintana JM, Aburto M, Moraza J, Capelastegui A. A simple score for assessing stable chronic obstructive pulmonary disease. QJM [Internet]. 2016

  39. [citado 21 Ene 2018]; 99:751-928. Disponible en: http://academic.oup.com/qjmed/article/99/11/751/2261128




2020     |     www.medigraphic.com